InsidersTradesSigma
Total declarations
Companies
▲ Purchases (23 ops.)
▼ Sales (28 ops.)
Insider track record
ExecutiveDisclosed buys
23
Disclosed sells
28
T+90 hit rate
33%
T+90 mean return
-21.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fletcher Aaron G.L., Director. Director active across 8 companies, notably Lantern Pharma Inc.. Aggregated, 67 disclosures have been recorded. Breakdown: 23 buys · 28 sells. Total volume traded: €9.3m. History available since 4 April 2022. The latest transaction was disclosed on 19 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Fletcher Aaron G.L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations67 total
25,000 sharesCommon StockSEC:0001789490-26-000002:0
7,729 shares@ US$0.840.7% of flowCommon StockSEC:0001104659-25-092671:0
71,428 shares@ US$7.000.68% mcap50.0% of flowCommon StockSEC:0001104659-25-063991:0
Canonical exit: 25 Sept 2025 (T+90)
34,000 shares0Common StockSEC:0001104659-25-061241:0
3 shares@ US$3.400.0000% mcap0.0% of flowCommon StockSEC:0001104659-25-059106:0
7,206 shares@ US$3.090.048% mcap50.0% of flowCommon StockSEC:0001104659-25-059528:0
3,790 shares@ US$3.051.2% of flowCommon StockSEC:0001104659-25-054422:0
2,702 shares@ US$2.870.8% of flowCommon StockSEC:0001104659-25-054422:1
3,639 shares@ US$3.031.2% of flowCommon StockSEC:0001104659-25-054422:2
6,479 shares@ US$3.052.1% of flowCommon StockSEC:0001104659-25-054422:3
4,620 shares@ US$2.871.4% of flowCommon StockSEC:0001104659-25-054422:4
6,221 shares@ US$3.032.0% of flowCommon StockSEC:0001104659-25-054422:5
1,000 shares@ US$3.050.3% of flowCommon StockSEC:0001104659-25-054422:6
714 shares@ US$2.870.2% of flowCommon StockSEC:0001104659-25-054422:7
961 shares@ US$3.030.3% of flowCommon StockSEC:0001104659-25-054422:8
7,478 shares@ US$3.052.4% of flowCommon StockSEC:0001104659-25-054422:9
5,332 shares@ US$2.871.6% of flowCommon StockSEC:0001104659-25-054422:10
7,180 shares@ US$3.032.3% of flowCommon StockSEC:0001104659-25-054422:11
2,290 shares@ US$3.050.7% of flowCommon StockSEC:0001104659-25-054422:12
1,632 shares@ US$2.870.5% of flowCommon StockSEC:0001104659-25-054422:13
2,199 shares@ US$3.030.7% of flowCommon StockSEC:0001104659-25-054422:14
5,314 shares@ US$8.004.3% of flowCommon StockSEC:0001104659-24-091371:0
884,427 sharesCommon StockSEC:0001104659-24-089822:0
8,500 shares0Common StockSEC:0001104659-24-070572:0
930 shares@ US$6.250.8% of flowCommon StockSEC:0001104659-24-065616:0
25 of 67 declarations
About Fletcher Aaron G.L.
Fletcher Aaron G.L. is a Director and has reported 67 filings in total. Across the 67 sampled filings between 2021-06-30 and 2026-06-22, buy amounts are EUR 8427542 and sell amounts are EUR 825757, with the modal transaction nature listed as Cession. The companies listed are Lantern Pharma Inc., Cognition Therapeutics INC, IN8BIO, INC., SWK Holdings Corp, Actuate Therapeutics, INC. and TFF Pharmaceuticals, Inc.
